In 2017, George Church was interviewed in Endpoints. The interview with George Church at Endpoints is the source of the next three paragraphs in italics, which are statements from George Church.
George Church describes the roadmap for to human aging reversal treatments
We will see the first aging reversal test in dog trials in the next year or two. If that works, human trials are another two years away, and eight years before they’re done. Once you get a few going and succeeding it’s a positive feedback loop.
His company Rejuvenate Bio is actually working on the dog trial now.
The particular dog model we’re using has a heart disease issue. Rejuvenate Bio was still in semi-stealth mode, incubator mode, but the trial was not a secret. Dogs are a market in and of themselves. [Tens of billions of dollars per year] It’s not just a big organism close to humans. It’s something people will pay for. The FDA process is much faster for dogs than for humans — a little over a year versus nine years or so.
Now two years later the dog heart treatment is fully public.
In 2018, George Church described using a combination of 45 gene therapies to reverse aging.
They have delivered 45 gene therapies to provide aging reversal. They find the combined treatment is effective against obesity, diabetes, osteoarthritis, cardiac damage and kidney disease.
SOURCES – Rejuvenate Bio, youtube